
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 27 results:
[ Author
Filters: First Letter Of Last Name is Y [Clear All Filters]
“Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK”, J Diabetes Complications, vol. 22, pp. 235-40, 2008.
, “Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia”, Am J Med, vol. 131, pp. 317.e11-317.e22, 2018.
, “Incretin-based drugs and the risk of congestive heart failure”, Diabetes Care, vol. 38, pp. 277-84, 2015.
, “The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death”, Can J Diabetes, vol. 39, pp. 383-9, 2015.
, “History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis”, Int J Womens Health, vol. 7, pp. 913-8, 2015.
, “Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013”, Rheumatology (Oxford), vol. 56, pp. 1902-1917, 2017.
, , “Underrecording of osteoarthritis in United Kingdom primary care electronic health record data”, Clin Epidemiol, vol. 10, pp. 1195-1201, 2018.
, “Co-prescription of gabapentinoids and opioids among adults with and without osteoarthritis in the United Kingdom between 1995 and 2017”, Rheumatology (Oxford), 2020.
, “Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom”, JAMA Surg, vol. 150, pp. 1126-33, 2015.
, “Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study”, BMJ Open, vol. 7, p. e017729, 2017.
, “Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database”, Br J Haematol, vol. 149, pp. 855-64, 2010.
, “Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink”, Br J Dermatol, 2020.
, , “Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort”, PLoS Med, vol. 14, p. e1002457, 2017.
, “Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012”, BMJ Open, vol. 8, p. e020528, 2018.
, “Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink”, Br J Cancer, vol. 115, pp. 85-9, 2016.
, “Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink”, Cancer Epidemiol, vol. 43, pp. 105-11, 2016.
, “Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients”, Gastroenterology, vol. 127, pp. 1044-50, 2004.
, “Type 2 diabetes mellitus and the risk of colorectal cancer”, Clin Gastroenterol Hepatol, vol. 3, pp. 587-94, 2005.
, “Chronic statin therapy and the risk of colorectal cancer”, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
, “Chronic proton pump inhibitor therapy and the risk of colorectal cancer”, Gastroenterology, vol. 133, pp. 748-54, 2007.
, “Statins and the risk of idiopathic venous thromboembolism”, Br J Clin Pharmacol, vol. 53, pp. 101-5, 2002.
, “Lipid-lowering drugs and the risk of depression and suicidal behavior”, Arch Intern Med, vol. 163, pp. 1926-32, 2003.
, “Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics”, Br J Clin Pharmacol, vol. 56, pp. 84-91, 2003.
, “Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation”, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
, ,